Patents by Inventor Roberto Elosua Llanos

Roberto Elosua Llanos has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11814673
    Abstract: The invention relates to a method for the reclassification of a subject to a more appropriate risk assessment to that obtained using the algorithms for such risk estimation such us but not limited to Framingham, Regicor, Score, Procamor Qrisk based on the presence of different polymorphisms. The invention also relates to a method for determining the risk of suffering a cardiovascular disease by combining the absence or presence of one or more polymorphic markers in a sample from the subject with conventional risk factors for CVD as well as computer-implemented means for carrying out said method.
    Type: Grant
    Filed: August 1, 2012
    Date of Patent: November 14, 2023
    Assignee: GENinCode PLC
    Inventors: Eduardo Salas Pérez-Rasilla, Jaume Marrugat De La Iglesia, Roberto Elosua Llanos, Sergio Castillo Fernandez, Joan Salgado Gomez, José Maria Ordovás Munoz
  • Publication number: 20220380849
    Abstract: The invention relates to a method for a more appropriate thromboembolic event risk assessment based on the presence of different genetic variant. The invention also relates to a method for determining the risk of suffering a thromboembolism disease by combining the absence or presence of one or more polymorphic markers in a sample from the subject with conventional risk factors for thromboembolism as well as computer-implemented means for carrying out said method.
    Type: Application
    Filed: May 25, 2021
    Publication date: December 1, 2022
    Applicant: Genincode UK, Ltd.
    Inventors: Matthew Heaton Walls, Marta Carrera, José Manuel Soria, Roberto Elosua Llanos
  • Publication number: 20220049306
    Abstract: The invention relates to a method for the reclassification of a subject to a more appropriate risk assessment to that obtained using the algorithms for such risk estimation such us but not limited to Framingham, Regicor, Score, Procamor Qrisk based on the presence of different polymorphisms. The invention also relates to a method for determining the risk of suffering a cardiovascular disease by combining the absence or presence of one or more polymorphic markers in a sample from the subject with conventional risk factors for CVD as well as computer-implemented means for carrying out said method.
    Type: Application
    Filed: May 25, 2021
    Publication date: February 17, 2022
    Applicant: Genincode UK, Ltd.
    Inventors: Matthew Heaton Walls, Marta Carrera, Jaume Marrugat De La Iglesia, Roberto Elosua Llanos
  • Patent number: 10557170
    Abstract: The invention relates to a method for a more appropriate thromboembolic event risk assessment based on the presence of different genetic variant. The invention also relates to a method for determining the risk of suffering a thromboembolism disease by combining the absence or presence of one or more polymorphic markers in a sample from the subject with conventional risk factors for thromboembolism as well as computer-implemented means for carrying out said method.
    Type: Grant
    Filed: July 17, 2017
    Date of Patent: February 11, 2020
    Assignee: Gendiag.exe, S.L.
    Inventors: Eduardo Salas, José Manuel Soria, Miroslava Ogorelkova, Roberto Elosua Llanos, Joan Vila, Sergio Castillo Fernandez
  • Patent number: 9957565
    Abstract: The invention relates to a method for determining the risk of suffering a cardiovascular disease based on the presence of different polymorphisms as well as to kits for practicing the above method. The invention also relates to a method for determining the risk of suffering a cardiovascular disease by combining the absence or presence of one or more polymorphic markers in a sample from the subject with conventional risk factors for CVD as well as computer-implemented means for carrying out said method.
    Type: Grant
    Filed: June 9, 2010
    Date of Patent: May 1, 2018
    Assignee: Gendiag.exe, S.L.
    Inventors: Eduardo Salas Pérez-Rasilla, Jaume Marrugat De La Iglesia, Roberto Elosua Llanos, Sergio Castillo Fernandez, Joan Salgado Gómez, Jose Maria Ordovás Munoz
  • Publication number: 20180066313
    Abstract: The invention relates to a method for a more appropriate thromboembolic event risk assessment based on the presence of different genetic variant. The invention also relates to a method for determining the risk of suffering a thromboembolism disease by combining the absence or presence of one or more polymorphic markers in a sample from the subject with conventional risk factors for thromboembolism as well as computer-implemented means for carrying out said method.
    Type: Application
    Filed: July 17, 2017
    Publication date: March 8, 2018
    Applicant: Gendiag.exe, S.L.
    Inventors: Eduardo Salas, José Manuel Soria, Miroslava Ogorelkova, Roberto Elosua Llanos, Joan Vila, Sergio Castillo Fernandez
  • Patent number: 9518297
    Abstract: The invention relates to a method for a more appropriate thromboembolic event risk assessment based on the presence of different genetic variant. The invention also relates to a method for determining the risk of suffering a thromboembolism disease by combining the absence or presence of one or more polymorphic markers in a sample from the subject with conventional risk factors for thromboembolism as well as computer-implemented means for carrying out said method.
    Type: Grant
    Filed: June 13, 2012
    Date of Patent: December 13, 2016
    Assignee: Gendiag.exe, S.L.
    Inventors: Eduardo Salas, José Manuel Soria, Miroslava Ogorelkova, Roberto Elosua Llanos, Joan Vila, Sergio Castillo
  • Publication number: 20160102355
    Abstract: The invention relates to a method for a more appropriate thromboembolic event risk assessment based on the presence of different genetic variant. The invention also relates to a method for determining the risk of suffering a thromboembolism disease by combining the absence or presence of one or more polymorphic markers in a sample from the subject with conventional risk factors for thromboembolism as well as computer-implemented means for carrying out said method.
    Type: Application
    Filed: October 19, 2015
    Publication date: April 14, 2016
    Applicant: Gendiag.exe, S.L.
    Inventors: Eduardo Salas, José Manuel Soria, Miroslava Ogorelkova, Roberto Elosua Llanos, Joan Vila, Sergio Castillo Fernandez
  • Publication number: 20140342355
    Abstract: The invention relates to a method for the reclassification of a subject to a more appropriate risk assessment to that obtained using the algorithms for such risk estimation such us but not limited to Framingham, Regicor, Score, Procamor Qrisk based on the presence of different polymorphisms. The invention also relates to a method for determining the risk of suffering a cardiovascular disease by combining the absence or presence of one or more polymorphic markers in a sample from the subject with conventional risk factors for CVD as well as computer-implemented means for carrying out said method.
    Type: Application
    Filed: August 1, 2012
    Publication date: November 20, 2014
    Applicant: Gendiag.exe, S.L.
    Inventors: Eduardo Salas Pérez-Rasilla, Jaume Marrrugat De La Iglesia, Roberto Elosua Llanos, Sergio Castillo Fernández, Joan Salgado Gómez, José Maria Ordovás Munoz
  • Publication number: 20140221230
    Abstract: The invention relates to a method for a more appropriate thromboembolic event risk assessment based on the presence of different genetic variant. The invention also relates to a method for determining the risk of suffering a thromboembolism disease by combining the absence or presence of one or more polymorphic markers in a sample from the subject with conventional risk factors for thromboembolism as well as computer-implemented means for carrying out said method.
    Type: Application
    Filed: June 13, 2012
    Publication date: August 7, 2014
    Applicant: Gendiag.exe, S.L.
    Inventors: Eduardo Salas, José Manuel Soria, Miroslava Ogorelkova, Roberto Elosua Llanos, Joan Vila, Sergio Castillo
  • Publication number: 20120141450
    Abstract: The invention relates to a method for determining the risk of suffering a cardiovascular disease based on the presence of different polymorphisms as well as to kits for practicing the above method. The invention also relates to a method for determining the risk of suffering a cardiovascular disease by combining the absence or presence of one or more polymorphic markers in a sample from the subject with conventional risk factors for CVD as well as computer-implemented means for carrying out said method.
    Type: Application
    Filed: June 9, 2010
    Publication date: June 7, 2012
    Applicant: GENDIAG.EXE, S.L.
    Inventors: Eduardo Salas Pérez-Rasilla, Jaume Marrugat De La Iglesia, Roberto Elosua Llanos, Sergio Castillo Fernandez, Joan Salgado Gómez, Jose Maria Ordovás Munoz